RTW Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$159M	Hold	7,144,524	–	–	1.58%	19
2025 Q4	$191M	Hold	7,144,524	–	–	1.91%	14
2025 Q3	$152M	Sell	7,144,524 -1,851,023	-21%	-$43.8M	1.88%	16
2025 Q2	$194M	Buy	8,995,547 +455,430	+5%	+$8.47M	2.76%	13
2025 Q1	$142M	Sell	8,540,117 -165,384	-2%	-$3M	2.17%	17
2024 Q4	$160M	Sell	8,705,501 -5,002,005	-36%	-$80.7M	2.42%	16
2024 Q3	$211M	Hold	13,707,506	–	–	3.05%	12
2024 Q2	$223M	Sell	13,707,506 -121,809	-0.9%	-$1.97M	3.45%	11
2024 Q1	$256M	Buy	13,829,315 +2,575,764	+23%	+$63.8M	3.77%	7
2023 Q4	$352M	Sell	11,253,551 -322,986	-3%	-$7.71M	5.5%	5
2023 Q3	$241M	Buy	11,576,537 +1,793,288	+18%	+$48.7M	5.09%	7
2023 Q2	$234M	Buy	9,783,249 +1,540,385	+19%	+$34.2M	4.46%	8
2023 Q1	$155M	Buy	8,242,864 +4,571,926	+125%	+$87.1M	3.23%	13
2022 Q4	$58.4M	Hold	3,670,938	–	–	1.19%	21
2022 Q3	$60.1M	Sell	3,670,938 -553,171	-13%	-$8.96M	1.38%	25
2022 Q2	$59.5M	Buy	+4,224,109	New	+$78.8M	1.54%	24